Company Profile
Updated: 17-SEP-09Affymetrix Inc.
Public Company, Headquarters Location
3420 Central Expy., Santa Clara, CA 95051-0703, United States
(888)362-2447, (408)731-5000, (408)731-5380 fax, http://www.affymetrix.com
Primary SIC: Laboratory Analytical Instruments, Primary NAICS: Analytical Laboratory Instrument Manufacturing
Description: Manufacturing: Genome research diagnostics instruments. Services: Engaged in commercial physical and biological research and development. More
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
Research from University of Pittsburgh, Medical Department reveals new findings on gastroenterology.
Genomics & Genetics Weekly; 11/13/2009; 883 words; ...with microarrays. To improve our analysis, we annotated the Affymetrix Zebrafish GeneChip with human orthologs. Transcriptional profiling...the journal Gastroenterology is: W B Saunders Co-Elsevier Inc., 1600 John F Kennedy Boulevard, Ste. 1800, Philadelphia...
Developing Countries Sign up for Pharmacogenomics for Every Nation Initiative Using the Affymetrix DMET™ Plus Panel.
Biotech Week; 11/11/2009; 1321 words; Affymetrix, Inc. (Nasdaq:AFFX) announced that...decision-making process (see also Affymetrix, Inc.). Doctors understand that drug...S. Food and Drug Administration, Affymetrix Inc. This article was prepared by Biotech...
New retinitis pigmentosa study findings have been published by scientists at Montreal Children's Hospital.(Report)
Obesity, Fitness & Wellness Week; 11/7/2009; 890 words; ...study. Using a combination of animal models of human RP, Affymetrix expression array studies, RT-PCR and immunohistochemical...information for the journal Ophthalmic Genetics is: Taylor & Francis Inc., 325 Chestnut St., Suite 800, Philadelphia, PA 19106...
Other News To Note.
BIOWORLD Today; 11/4/2009; 1842 words; Affymetrix Inc., of Santa Clara, Calif., and the...entered a research collaboration to use Affymetrix GeneChip technology to conduct cancer...multiple clinical sites and studies. AnorMED Inc., of Vancouver, British Columbia...
Issue Of Patenting Genes Still Troubling For Biotech Industry.(Conference notes)
BIOWORLD Today; 11/4/2009; 1243 words; ...get a patent, according to Barbara Caulfield, a panel member and executive vice president and general counsel at Affymetrix Inc., of Santa Clara, Calif. As many have stated before, if a company can't guarantee investors certain protections...
Affymetrix knows the human body down to every last gene. This company has developed a system called GeneChip, along with other products, which manages, analyzes and identifies the human body's genes. This process has becomes more and more important as we now understand that many diseases and fatal illnesses can be detected in genes and therefore can be treated before a person is even conceived. To go hand in hand with this gene company, Glaxo, a pharmaceutical giant, hold about a 35% stake in the company. Their top competition comes from Abbott Labs, PE Corporation and Nycomed Amersham.
Recent News Articles
- FDA Calendar and News Updates for Elan Corporation (NYSE: ELN), Targacept (NASDAQ: TRGT), CytoDyn (OTC: CYDY) and Affymetrix, Inc. (Nasdaq:AFFX).
M2 Presswire - July 09, 2009 - Affymetrix Inc., (Nasdaq:AFFX) Hot Stock on the Move!
M2 Presswire - May 11, 2009 - Affymetrix Inc-Financial Company Report.
M2 Presswire - February 11, 2009 - Recent studies from Affymetrix, Inc. add new data to DNA research.
Biotech Week - December 03, 2008
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning
